Prevent Withdrawal Due to ICU Analgesics and Sedatives

March 2022

You’ll need to prevent “iatrogenic withdrawal syndrome” when stopping high doses of ICU analgesics and sedatives in adults.

High doses may be needed to achieve light sedation in some patients, especially those with COVID-19...or when deeper sedation is required for patients who have severe respiratory distress.

When stopping, take steps to prevent withdrawal...since it’s linked to longer ventilator or ICU time.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Immunizations Clarify New Guidelines for Prevnar 20 and Vaxneuvance
Corticosteroids Be Equipped With Rules of Thumb to Taper Steroids
Insulin Implement Safeguards for U-500 Insulin
Mental Health Be Ready to Ask Questions About Suicide
Pediatrics Shorten Antibiotic Durations for Kids With Community-Acquired Pneumonia
Neurology & Pain Compare Meds for Diabetic Neuropathy
Oral Health Reinforce Oral Care With Buccal or Sublingual Buprenorphine
Insomnia Be Prepared With Answers About Melatonin for Sleep
Eczema Watch for Adbry, Cibinqo, and Rinvoq for Eczema
Infectious Diseases Optimize Antibiotic Stewardship for Gram-Negative Bacteremia
COVID-19 Assess the Role of the New COVID-19 MAb, Bebtelovimab
Critical Care Prevent Withdrawal Due to ICU Analgesics and Sedatives

Prevent Withdrawal Due to ICU Analgesics and Sedatives

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents